81 filings
Page 4 of 5
8-K
b91x vbq8fu73ffun
13 Jul 20
Iterum Therapeutics Informs Shareholders of Record Date for Planned Rights Offering
4:30pm
8-K
alvrvmyg3ks
30 Jun 20
Iterum Therapeutics Announces $5 Million Registered Direct Offering PricedAt-the-Market under Nasdaq Rules
9:37pm
8-K
ojsv0lqghngs ms67pl
29 Jun 20
Sulopenem demonstrates superiority in treatment of patients with quinolone resistant pathogens
7:45am
8-K
lxyd14w1q
15 Jun 20
Material Modifications to Rights of Security Holders
4:45pm
8-K
ho2kfj992x v7n4l73q
4 Jun 20
Iterum Therapeutics Announces $5 Million Registered Direct Offering PricedAt-the-Market under Nasdaq Rules
5:28pm
8-K
xlsg3248gyef63gkd8yv
2 Jun 20
Iterum Therapeutics Announces Topline Results for a Phase 3 Clinical Trial of Oral and IV
9:57pm
8-K
vi9i86advkvh7 ld
15 May 20
Other Events
4:04pm
8-K
lo46wq
14 May 20
Iterum Therapeutics Reports First Quarter 2020 Financial Results
7:00am
8-K
ex04fe4a7sso2r6a
12 Mar 20
Iterum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
7:00am
8-K
4832xzba1p 9fyxy
6 Mar 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:30pm
8-K
21txsq25z7z7dr76jft
14 Feb 20
Departure of Directors or Certain Officers
12:00am
8-K
6frr8f27xdbby ya
17 Jan 20
Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors
6:23am
8-K
3ws37h6w vtwiy3yld
12 Nov 19
Iterum Therapeutics Reports Third Quarter 2019 Financial Results and Highlights
4:45pm
8-K
8mzoarbvhx3ol35i4m
14 Aug 19
Iterum Therapeutics Reports Second Quarter 2019 Financial Results
12:00am
8-K
g3860kbuds
17 Jun 19
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
pnh5r870 le
14 May 19
Iterum Therapeutics Reports First Quarter 2019 Financial Results
7:15am
8-K
tcvixrfataxsz
25 Mar 19
Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
7:16am
8-K
smii1d9
14 Nov 18
Iterum Reports Third Quarter 2018 Financial Results and Recent Highlights
7:31am
8-K
xmkufcpfqvtzzh9bqdt1
19 Oct 18
Regulation FD Disclosure
5:25pm
8-K
2hn19bxi387jwgp
14 Aug 18
Iterum Reports Second Quarter 2018 Financial Results and Recent Highlights
7:30am